Area of research
Molecular Biology · Cancer Research
Research interest
Research focused on Mesenchymal stem cell and Microvesicles, with related work in Inflammatory bowel disease, Nanomedicine, Extracellular vesicles. Notable publications include 'Extracellular vesicles: A bright star of nanomedicine', 'Exosome‐mediated effects and applications in inflammatory bowel disease', and 'Improved therapeutics of modified mesenchymal stem cells: an update'.
Mesenchymal stem cell in immunomodulation of dendritic cells: Implications for inflammatory bowel disease therapy
The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment
Intestinal mucus barrier: A potential therapeutic target for IBD
Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease
hucMSC-Ex alleviates inflammatory bowel disease in mice by enhancing M2-type macrophage polarization via the METTL3-Slc37a2-YTHDF1 axis
Therapeutic Prospects of Mesenchymal Stem Cell and Their Derived Exosomes in the Regulation of the Gut Microbiota in Inflammatory Bowel Disease
The Function of Necroptosis and Its Treatment Target in IBD
The role of mesenchymal stem cells in attenuating inflammatory bowel disease through ubiquitination
Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review)
Effects of DNA methylation and its application in inflammatory bowel disease (Review)
Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis
Current evidence and therapeutic implication of PANoptosis in cancer
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease
Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
Resveratrol alleviates DSS-induced IBD in mice by regulating the intestinal microbiota-macrophage-arginine metabolism axis
Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer
hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases
Exosome-mediated macrophage regulation for inflammatory bowel disease repair: a potential target of gut inflammation.
PubMed 2023cited by 7position: middle
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis
Mesenchymal stem cell-derived exosome mitigates colitis <i>via</i> the modulation of the gut metagenomics–metabolomics–farnesoid X receptor axis
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p/VEGFR3/AKT axis to ameliorate inflammatory bowel disease
The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease
hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis
Emerging roles of mesenchymal stem cell-derived exosomes in gastrointestinal cancers
hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis
Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease